FDA Scraps Its Juul Marketing Denials; Authorization Now Possible

The FDA rescinded marketing denial orders for Juul, allowing their vaping products to be back under scientific review after being pulled from the market in 2022. This move is crucial in the harm reduction and youth vaping debate. Critics say the FDA's decision was political, urging a swift final review. Although Juul retains tobacco- and menthol-flavored products, its future remains uncertain. Authorization could secure access for ex-smokers. The PMTA process has faced criticism for favoring big tobacco. Juul plans to engage in an evidence-based FDA process, hoping for approval. Youth vaping has declined, and stakeholders stress the need for swift FDA action.